Significant fibrosis predicts new-onset diabetes mellitus and arterial hypertension in patients with NASH by Ampuero, Javier, Aller, Rocío, Gallego-Durán, Rocío, Crespo, Javier, Calleja, José Luis, García-Monzón, Carmelo, Gómez-Camarero, Judith, Caballería, Joan, Lo Iacono, Oreste, Ibañez, Luis, García-Samaniego, Javier, Albillos, Agustín, Francés, Rubén, Fernández-Rodríguez, Conrado, Diago, Moisés, Soriano, Germán, Andrade, Raúl J., Latorre, Raquel, Jorquera, Francisco, Morillas, Rosa María, Escudero, Desamparados, Estévez, Pamela, Guerra, Manuel Hernández, Augustín, Salvador, Banales, Jesús M., Aspichueta, Patricia, Benlloch, Salvador, Rosales, José Miguel, Salmerón, Javier, Turnes, Juan, Romero Gómez, Manuel

Get full text

Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs by Llaneras, Jordi, Riveiro-Barciela, Mar, Lens, Sabela, Diago, Moisés, Cachero, Alba, García-Samaniego, Javier, Conde, Isabel, Arencibia, Ana, Arenas, Juan, Gea, Francisco, Torras, Xavier, Luis Calleja, José, Antonio Carrión, José, Fernández, Inmaculada, María Morillas, Rosa, Rosales, José Miguel, Carmona, Isabel, Fernández-Rodríguez, Conrado, Hernández-Guerra, Manuel, Llerena, Susana, Bernal, Vanesa, Turnes, Juan, González-Santiago, Jesús M., Montoliu, Silvia, Figueruela, Blanca, Badia, Ester, Delgado, Manuel, Fernández-Bermejo, Miguel, Iñarrairaegui, Mercedes, Pascasio, Juan Manuel, Esteban, Rafael, Mariño, Zoe, Buti, Maria

Get full text

Serum biomarkers can predict a change in liver fibrosis 1 year after lifestyle intervention for biopsy‐proven NASH by Vilar‐Gomez, Eduardo, Calzadilla‐Bertot, Luis, Friedman, Scott L., Gra‐Oramas, Bienvenido, Gonzalez‐Fabian, Licet, Lazo‐del Vallin, Sacha, Diago, Moises, Adams, Leon A.

Get full text

Reassessing HIV Detection Strategies: An Analysis of Opportunistic Screening vs. Indicator-Condition-Driven Diagnosis in Valencia, Spain by Ortega, Enrique, Ocete, María Dolores, Martínez-Roma, María, Gimeno, Concepción, Gómez, Neus, Diago, Moisés, Carrodeguas, Alba, Medina, Diogo, García-Deltoro, Miguel

Get full text

One-step diagnosis strategy together with multidisciplinary telematics referral perform an effective approach for identifying and treating patients with active Hepatitis C infectio... by Torrecillas, Miriam, Gómez-Muñoz, Neus, Ocete, María Dolores, Cuevas, Purificación Rubio, Madrid, Moisés Diago, González, Enrique Ortega, Cardona, Concepción Gimeno, García-Deltoro, Miguel

Get full text

The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis by Ampuero, Javier, Aller, Rocío, Gallego-Durán, Rocío, Crespo, Javier, Calleja, Jose Luis, García-Monzón, Carmelo, Gómez-Camarero, Judith, Caballería, Joan, Lo Iacono, Oreste, Ibañez, Luis, García-Samaniego, Javier, Albillos, Agustín, Francés, Rubén, Fernández-Rodríguez, Conrado, Maya-Miles, Douglas, Diago, Moisés, Poca, Maria, Andrade, Raúl J., Latorre, Raquel, Jorquera, Francisco, Morillas, Rosa María, Escudero, Desamparados, Hernández-Guerra, Manuel, Pareja-Megia, María Jesús, Banales, Jesús M., Aspichueta, Patricia, Benlloch, Salvador, Rosales, José Miguel, Turnes, Juan, Romero-Gómez, Manuel

Get full text

Impact of comorbidities on patient outcomes after interferon-free therapy-induced viral eradication in hepatitis C by Ampuero, Javier, Jimeno, Carlota, Quiles, Rosa, Rosales, José Miguel, Llerena, Susana, Palomo, Nieves, Cordero, Patricia, Serrano, Francisco Javier, Urquijo, Juan José, Moreno-Planas, José María, Ontanilla, Guillermo, Hernández, Marta, Ortega-Alonso, Aída, Maraver, Marta, Bonacci, Martín, Rojas, Ángela, Figueruela, Blanca, Forns, Xavier, Andrade, Raúl J., Calleja, José Luis, Diago, Moisés, Carmona, Isabel, de la Mata, Manuel, Buti, María, Crespo, Javier, Pascasio, Juan Manuel, Navarro, José María, Salmerón, Javier, Romero-Gómez, Manuel

Get full text

Daclatasvir vs telaprevir plus peginterferon alfa/ribavirin for hepatitis C virus genotype 1 by Jacobson, Ira, Zeuzem, Stefan, Flisiak, Robert, Knysz, Brygida, Lueth, Stefan, Zarebska-Michaluk, Dorota, Janczewska, Ewa, Ferenci, Peter, Diago, Moises, Zignego, Anna Linda, Safadi, Rifaat, Baruch, Yaacov, Abdurakhmanov, Dzhamal, Shafran, Stephen, Thabut, Dominique, Bruck, Rafael, Gadano, Adrian, Thompson, Alexander James, Kopit, Justin, McPhee, Fiona, Michener, Tracy, Hughes, Eric A, Yin, Philip D, Noviello, Stephanie

Get full text

Hospital admission is a relevant source of hepatitis C virus acquisition in Spain by Martínez-Bauer, Eva, Forns, Xavier, Armelles, Mercé, Planas, Ramon, Solà, Ricard, Vergara, Mercé, Fàbregas, Silvia, Vega, Roser, Salmerón, Javier, Diago, Moisés, Sánchez-Tapias, Jose María, Bruguera, Miquel

Get full text

Present and future of new systemic therapies for early and intermediate stages of hepatocellular carcinoma by Urquijo-Ponce, Juan Jose, Alventosa-Mateu, Carlos, Latorre-Sánchez, Mercedes, Castelló-Miralles, Inmaculada, Diago, Moisés

Get full text

Opportunistic population screening as a hepatitis elimination strategy: the CRIVALVIR-FOCUS program by Ortega González, Enrique, Ocete Mochón, María Dolores, Gimeno Cardona, Concepción, Martínez-Roma, María, Diago Madrid, Moisés, Gómez Muñoz, Neus, Carrodeguas, Alba, González-Sánchez, José Luis, García-Deltoro, Miguel

Get full text

Simeprevir with peginterferon α-2a/ribavirin for chronic hepatitis C virus genotype 1 infection in treatment-experienced patients: an open-label, rollover study by Gane, Edward J, DeJesus, Edwin, Janczewska, Ewa, George, Jacob, Diago, Moises, Da Silva, Mariliza Hendrique, Reesink, Henk, Nikitin, Igor, Hinrichsen, Holger, Bourgeois, Stefan, Ferenci, Peter, Shukla, Umesh, Kalmeijer, Ronald, Lenz, Oliver, Fevery, Bart, Corbett, Chris, Beumont, Maria, Jessner, Wolfgang

Get full text

Prediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study by Romero-Gómez, Manuel, Turnes, Juan, Ampuero, Javier, Oyagüez, Itziar, Cuenca, Beatriz, Gonzalez-Garcia, Juan, Muñoz-Molina, Belén, Aguilar, Rocio, Leal, Sandra, Planas, Ramon, Garcia-Samaniego, Javier, Diago, Moises, Crespo, Javier, Calleja, Jose Luis, Casado, Miguel Angel, Sola, Ricard

Get full text

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial by Goodman, Zachary, Sheikh, Muhammad Y, Mazzella, Giuseppe, Gluud, Lise Lotte, Shapiro, David, Campagna, Jason, Shringarpure, Reshma, Abdelmalek, Manal, Aigner, Elmar, Alazawi, William, Allison, Michael, Andreone, Pietro, Arenas Ruiz, Juan Ignacio, Arkkila, Perttu, Berenguer, Marina, Bradley, David, Braun, Marius, Bruno, Savino, Calderon, Amy, Carey, Elizabeth, Cave, Matthew, Cruz Pereira, Oscar, de Ledinghen, Victor, Dufour, Jean-François, Falcone, Robert, Ferreira, Jose, Finnegan, Kevin, Francque, Sven, Freilich, Bradley, Frias, Juan, Fuchs, Michael, Fuentes, Javier, Geerts, Anja, Geier, Andreas, George, Jacob, Gholam, Pierre, Goff, John, Gordon, Frederic, Greer, Shaun, Gunaratnam, Naresh, Harrison, Stephen, Hartleb, Marek, Heurich, Eva, Holland Fischer, Peter, Jeffers, Lennox, Kaita, Kelly, Kechagias, Stergios, Knapple, Whitfield, Korenblat, Kevin, Krag, Aleksander, Krause, Richard, Krok, Karen, Kuwada, Scott, Lee, Alice, Long, Michelle, Lurie, Yoav, Macedo, Guilherme, Mantry, Parvez, Marinho, Carla, Marschall, Hanns-Ulrich, McCullen, Mark, Molina, Esther, Montano-Loza, Aldo, Monteverde, Carlos, Muellhaupt, Beat, Naik, Jahnavi, Nguyen-Khac, Eric, Olveira, Antonio, Orr, David, Paredes, Angelo, Patel, Joykumar, Patel, Keyur, Piekarska, Anna, Pyrsopoulos, Nikolaos, Rafiq, Nila, Muller, Kate, Riera, Andres, Rinella, Mary, Rivera Acosta, Jose, Rushbrook, Simon, Ryan, Michael, Salminen, Kimmo, Schneider, Jeffrey, Sheikh, Aasim, Sheridan, David, Sherman, Kenneth, Siddique, Asma, Solis, Joel, Strasser, Simone, Svorcan, Petar, Talal, Andrew, Thuluvath, Paul, Tsochatzis, Emanuel, Veitsman, Ella, Vespasiani Gentilucci, Umberto, Victor, David, von der Ohe, Manfred, Waters, Michael, Wieland, Amanda, Yataco, Maria

Get full text

Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C by Romero-Gómez, Manuel, Fernández-Rodríguez, Conrado M, Andrade, Raúl J, Diago, Moisés, Alonso, Sonia, Planas, Ramón, Solá, Ricard, Pons, José A, Salmerón, Javier, Barcena, Rafael, Perez, Ramón, Carmona, Isabel, Durán, Santiago

Get full text

Prevalence of non‐alcoholic fatty liver and liver fibrosis in patients with moderate–severe psoriasis: A cross‐sectional cohort study by Magdaleno‐Tapial, Jorge, Valenzuela‐Oñate, Cristian, Ortiz‐Salvador, José María, Martínez‐Doménech, Álvaro, García‐Legaz‐Martínez, Marta, Alonso‐Carpio, Miriam, Tamarit‐García, Juan José, Diago‐Madrid, Moisés, Sánchez‐Carazo, José Luis, Pérez‐Ferriols, Amparo

Get full text

No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B by Wei, Lai, Wedemeyer, Heiner, Liaw, Yun-Fan, Chan, Henry Lik-Yuen, Piratvisuth, Teerha, Marcellin, Patrick, Jia, Jidong, Tan, Deming, Chow, Wan-Cheng, Brunetto, Maurizia R, Diago, Moisés, Gurel, Selim, Morozov, Viacheslav, He, Hua, Zhu, Yonghong, Wat, Cynthia, Surujbally, Bernadette, Thompson, Alexander J

Get full text

P-13 EVALUATION OF UNDIAGNOSED ALCOHOLIC LIVER DISEASE IN PATIENTS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE USING THE ANI SCORE by Mateu, Carlos Alventosa, Sánchez, Mercedes Latorre, Miralles, Inmaculada Castelló, Díaz, Benjamín Climent, Ponce, Juan José Urquijo, Madrid, Moisés Diago

Get full text

A global research priority agenda to advance public health responses to fatty liver disease by Allen, Alina M., Alqahtani, Saleh A., Arrese, Marco, Castro-Narro, Graciela E., Dedes, Nikos, Duseja, Ajay, Huang, Terry T.-K., Kautz, Achim, Newsome, Philip N., Rinella, Mary E., Sarin, Shiv Kumar, Valenti, Luca, Schattenberg, Jörn M., Younossi, Zobair M., Castro-Narro, Graciela E., Duseja, Ajay, Hagström, Hannes, Wajcman, Dana Ivancovsky, Kautz, Achim, Krag, Aleksander, Newsome, Philip N., Silva, Marcelo, Valenti, Luca, Al-Naamani, Khalid, Allison, Michael, Alnaser, Faisal A., Alswat, Khalid, Awuku, Yaw Asante, Baatarkhuu, Oidov, Bakieva, Shokhista, Barouki, Robert, Batterham, Rachel L., Berzigotti, Annalisa, Bianco, Cristiana, Brunt, Elizabeth M., Bugianesi, Elisabetta, Byrne, Christopher J., Castillo-López, Maria Gabriela, Coppell, Kirsten, Cotrim, Helma P., Crespo, Javier, Demir, Münevver, Dirac, M. Ashworth, Elsanousi, Osama M., Elsharkawy, Ahmed M., Eskridge, Wayne, Freidman, Scott L., Gadano, Adrian, George, Jacob, Girala, Marcos, Goossens, Nicolas, Henry, Zachary, Hickman, Ingrid J., Isakov, Vasily A., Jornayvaz, François, Koek, Ger, Kondili, Loreta A., Kotsiliti, Eleni, Koulla, Yiannoula, Kugelmas, Marcelo, Lkhagvaa, Undram, Malekzadeh, Reza, Martínez Vázquez, Sophia E., Mateva, Lyudmila, Mato, José M., Mendive, Juan M., Mikolasevic, Ivana, Milovanovic, Tamara, Musso, Carla, Nava-González, Edna J., Negro, Francesco, Nersesov, Alexander V., Neuschwander-Tetri, Brent A., Ong, Janus P., Ong-Go, Arlinking, Onyekwere, Charles, Pais, Raluca, Panduro, Arturo, Paruk, Imran, Pérez-Escobar, Juanita, Marques Souza de Oliveira, Claudia Pinto, Rabiee, Atoosa, Ramji, Alnoor, Ratziu, Vlad, Romeo, Stefano, Rowe, Ian A., Serme, Abdel Karim, Sharvadze, Lali, Skrypnyk, Igor, Song, Myeong Jun, Sookoian, Silvia, Swain, Mark G., Tan, Soek-Siam, Tapper, Elliot B., Tiniakos, Dina, Torre, Aldo, Turcanu, Adela, Velarde Ruiz Velasco, Jose Antonio, Vilar-Gomez, Eduardo, Wattacheril, Julia

Get full text

Safety and effectiveness of vaccines agains SARS-COV-2 in patients with liver cancer. VacHep registry: response analysis 4 weeks after the second dose by Sempere, Elena Diago, Matilla, Ana, Rodríguez, Carlos, Perelló, Christie, Minguez, Beatriz, Varela, Maria, Urquijo, Juan José, Ampuero, Javier, Prieto, Janire, Pérez, Laura Márquez, Crespo, Javier, Bermúdez, María, Piedra Cerezal, Ana Maria, Diago, Moises, Antoran, Belén Ruiz, Calleja Panero, José Luis

Get full text